Clinical Trials Directory

Trials / Unknown

UnknownNCT05686915

MARS MRI in Revision THA With a Ceramic Femoral Head and Titanium Sleeve

Metal Artifact Reduction Sequence MRI in Revision Total Hip Arthroplasty With a Ceramic Femoral Head and Titanium Sleeve

Status
Unknown
Phase
Study type
Observational
Enrollment
55 (estimated)
Sponsor
Colorado Joint Replacement · Academic / Other
Sex
All
Age
18 Years – 99 Years
Healthy volunteers
Not accepted

Summary

Revision total hip replacement using a ceramic head utilizes a titanium sleeve which introduced another articulation into the system that may lead to a local soft tissue reaction. The purpose of this study is to determine the frequency, size and types of MRI documented local tissue reactions in individuals doing well after a revision total hip replacement and ceramic bearing surface that utilizes a titanium sleeve.

Detailed description

Metal-on-metal total hip arthroplasty (THA) were heralded as a solution for two of the most common problems in hip arthroplasty in the last decade, instability and osteolysis. Unfortunately, their failures have led to diminished enthusiasm for this bearing surface. Adverse local tissue reactions (ATLRs) have been well documented as a means of pain and failure in this population. A recent report revealed that the most commonly used bearing surface in total hip arthroplasty, metal-on-polyethylene, may have up to a 28% incidence of MRI abnormalities in asymptomatic hips. Revision THA using a ceramic head utilizes a titanium sleeve which introduced another articulation into the system that may lead to a local soft tissue reaction. The purpose of this study is to determine the frequency, size and types of MRI documented local tissue reactions in asymptomatic individuals after a revision THA and ceramic bearing surface that utilizes a titanium sleeve. To our knowledge, this has not been studied previously and may provide important baseline features of this diagnostic tool with this particular bearing surface. We hypothesize that there will be fluid collections in a small but clinically significant portion of asymptomatic patients.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTMARS MRImetal artifact reduction sequence (MARS) MRI to assess for fluid collections, ATLRs or other abnormalities
DIAGNOSTIC_TESTTitanium LabsLabs to look at titanium levels in blood
DIAGNOSTIC_TESTCobalt LabsLabs to look at cobalt levels in blood
DIAGNOSTIC_TESTChromium LabsLabs to look at chromium levels in blood

Timeline

Start date
2022-12-22
Primary completion
2023-06-01
Completion
2023-12-31
First posted
2023-01-17
Last updated
2023-01-17

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT05686915. Inclusion in this directory is not an endorsement.